Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
Recruiting · NCT07267806 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC | Chemotherapy Effect; Hepato Cellular Carcinoma (HCC) | Recruiting | Phase 3 | 2025-12-16 | NCT07267806 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Linhui Peng | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen Memorial Hospital of Sun Yat-sen University | Guangzhou | China | 12 |